Stock Splits
By The Online Investor Staff, updated Tue., Dec. 1, 4:18 AM
| This Slide: #4 of 25 |
Slide #4. HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) — 1 for 15 Reverse Split
Announced:
11/23/2020
Stock Split:
1 for 15
Record Date:
11/20/2020
Pay Date:
11/23/2020
HTGM Optionable?:
Yes
HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay;HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel. 
HTGM Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the HTGM Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.60 out of 4) 65th percentile
(ranked higher than approx. 65% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
